Interferential Current And Trapezius Myofascial Trigger Points

NCT05275634 | Completed

• 1 other identifier: P.T.REC/012/003591
• Study Type: interventional
• Target: 68
• Locations: 1 country
• Sites: 1

Brief Summary

To investigate the effect of different carrier frequencies of interferential current on pressure pain threshold, neck disability, cervical range of motion and upper trapezius muscle activity when applied on upper trapezius chronic myofascial trigger points: Randomized Controlled Trial

Conditions

Upper Trapezius Trigger Points

Keywords

Interferential current; Carrier frequency; Upper trapezius; Trigger points

Outcome Measures

Primary Outcomes (1)

• Change in pressure pain threshold

  Pressure pain threshold will be measured by digital pressure algometer

  Immediately after the end of the treatment

Secondary Outcomes (7)

• Change in Pressure pain threshold

  12 weeks following the end of the treatment

• Change in neck disability

  Immediately after the end of the treatment

• Change in neck disability

  12 weeks following the end of the treatment

• Change in cervical range of motion

  Immediately after the end of the treatment

• Change in cervical range of motion

  12 weeks following the end of the treatment

Study Arms (4)

Standard treatment and interferential current with carrier frequency 2 KHz

EXPERIMENTAL

Standard treatment and interferential current with carrier frequency 2 KHz will be received three times a week for four weeks.

Other: Stander treatment; Device: Interferential current with carrier frequency 2 KHz

Standard treatment and interferential current with carrier frequency 4 KHz

EXPERIMENTAL

Standard treatment and interferential current with carrier frequency 4 KHz will be received three times a week for four weeks.

Other: Stander treatment; Device: Interferential current with carrier frequency 4 KHz

Standard treatment and interferential current with carrier frequency 8 KHz

EXPERIMENTAL

Standard treatment and interferential current with carrier frequency 8 KHz will be received three times a week for four weeks.

Other: Stander treatment; Device: Interferential current with carrier frequency 8 KHz

Standard treatment and placebo interferential current

PLACEBO COMPARATOR

Standard treatment and placebo interferential current will be received three times a week for four weeks.

Other: Stander treatment; Device: placebo interferential current

Interventions

Stander treatment OTHER

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

Standard treatment and interferential current with carrier frequency 2 KHz; Standard treatment and interferential current with carrier frequency 4 KHz; Standard treatment and interferential current with carrier frequency 8 KHz; Standard treatment and placebo interferential current

Interferential current with carrier frequency 2 KHz DEVICE

Interferential current treatment parameters will be as following; carrier frequency 2 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and interferential current with carrier frequency 2 KHz

Interferential current with carrier frequency 4 KHz DEVICE

Interferential current treatment parameters will be as following; carrier frequency 4 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and interferential current with carrier frequency 4 KHz

Interferential current with carrier frequency 8 KHz DEVICE

Interferential current treatment parameters will be as following; carrier frequency 8 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and interferential current with carrier frequency 8 KHz

placebo interferential current DEVICE

Interferential current intensity will not be raised.

Standard treatment and placebo interferential current

Eligibility Criteria

• Age: 18 Years - 29 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Ages from18-29 years old with unilateral chronic myofascial trigger points in upper trapezius muscle will be included in this study.
• Participants have chronic myofascial trigger points if they have pain with pressure, local twitch response, jump sign, limited range of motion and referred pain lies over the lateral aspect of the upper trapezius fibers and superiorly to the ipsilateral occiput.
• Normal body mass index (BMI) from 18-24.9 Kg/m (BMI = body mass in kg divided by participant height in meters).

You may not qualify if:

• Onset of pain less than 3 months
• History of whiplash injury
• History of cervical spine surgery
• Cervical radiculopathy or myelopathy and cervical disc lesion
• Cervical spondylolisthesis
• Having multiple sclerosis, thyroid dysfunction and chronic infection
• Having rheumatologic condition as poly articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases
• Skin disease and impaired sensation
• Phobia of using electrical current
• Pregnancy, tumor, thrombosis and pacemaker
• Administration of regular analgesic drugs or any medications that affect skin sensation.
• Receiving physical therapy intervention during the past three months.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Faculty of Physical Therapy Cairo University

Giza, 12511, Egypt

Location

Related Publications (2)

• Venancio RC, Pelegrini S, Gomes DQ, Nakano EY, Liebano RE. Effects of carrier frequency of interferential current on pressure pain threshold and sensory comfort in humans. Arch Phys Med Rehabil. 2013 Jan;94(1):95-102. doi: 10.1016/j.apmr.2012.08.204. Epub 2012 Aug 23.

  PMID: 22922327 BACKGROUND

• Correa JB, Costa LO, Oliveira NT, Lima WP, Sluka KA, Liebano RE. Effects of the carrier frequency of interferential current on pain modulation and central hypersensitivity in people with chronic nonspecific low back pain: A randomized placebo-controlled trial. Eur J Pain. 2016 Nov;20(10):1653-1666. doi: 10.1002/ejp.889. Epub 2016 May 6.

  PMID: 27150263 BACKGROUND

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Masking Details: Double (Participant, Outcomes Assessor)
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Lecturer

Model Details: This trial has four groups; three experimental and one group control.

Study Record Dates

• First Submitted: February 15, 2022
• First Posted: March 11, 2022
• Study Start: June 1, 2022
• Primary Completion: January 31, 2023
• Study Completion: January 31, 2023
• Last Updated: May 26, 2023

Record last verified: 2023-05

Locations

EG (1)